Therapeutic options in childhood nocturnal enuresis

Area of Science:

• Pediatric Urology
• Sleep Medicine
• Behavioral Therapy

Background:

• Monosyllomatic nocturnal enuresis is common in children over 5 years old.
• Various treatments exist, but long-term efficacy varies.
• Enuresis alarms and pharmacotherapy (desmopressin, tricyclic antidepressants) are common interventions.

Purpose of the Study:

• To evaluate the effectiveness of different treatment modalities for monosymptomatic nocturnal enuresis.
• To compare the long-term benefits of combined therapies versus pharmacotherapy.
• To explore the role of pharmacotherapy in motivating behavioral interventions.

Main Methods:

• Review of existing literature on enuresis alarm therapy, pharmacotherapy (desmopressin, tricyclic antidepressants), and combined treatment approaches.
• Analysis of treatment outcomes, including rates of dryness and relapse.
• Assessment of the impact of pharmacotherapy on adherence to behavioral interventions.

Main Results:

• Enuresis alarms and combined therapies demonstrate greater effectiveness than pharmacotherapy alone.
• Pharmacotherapy (desmopressin, tricyclic antidepressants) effectively reduces wet nights but often leads to relapse upon discontinuation.
• Combined therapy, particularly desmopressin with alarm therapy, shows positive effects.
• Achieving dryness with pharmacotherapy can motivate children to continue behavioral therapy.

Conclusions:

• Combined therapeutic approaches offer the most significant long-term benefits for managing monosymptomatic nocturnal enuresis.
• Pharmacotherapy can provide rapid initial symptom relief and serve as a motivator for sustained behavioral interventions.
• A multimodal strategy integrating behavioral and pharmacological methods is recommended for optimal outcomes in pediatric enuresis treatment.